"Improving efficiency and outcomes in breast cancer detection supports our healthymagination commitment to delivering high-quality healthcare at a lower cost," said David Lee, head of Health Economics and Reimbursement for GE Healthcare in the United States and Canada. "We are pleased to work with RadNet to pilot our breast cancer detection optimization model in the clinical setting and look forward to identifying opportunities to improve the diagnosis and treatment of breast cancer while increasing efficiency and cost savings." GE Healthcare's Best Pathways initiative was developed in collaboration with academic and community mammographers, primary care physicians and breast surgeons to explore alternative detection strategies and understand the need for new diagnostic technologies. Through its participation and eventual findings to be released publicly, RadNet will be able to refine and customize its breast cancer detection processes for its imaging centers for improved efficiency and better patient care.